Screener
Vaxcyte, Inc. PCVX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$320.62M-128% | -$246.51M-79.8% | -$212.83M-106% | -$166.57M-29.4% | -$140.72M-48.1% | ||
| $2.95M-0.3% | $7.5M+162% | $3.06M+71.4% | $2.88M+113% | $2.96M+196% | ||
| $37.96M+24.0% | $36M+47.7% | $35.31M+66.0% | $36.93M+71.3% | $30.62M+73.7% | ||
| -$280.63M-68.8% | -$224.83M-102% | -$143.31M-136% | -$121.17M+0.2% | -$166.27M-4.5% | ||
| $2.11M-61.2% | $2.65M-34.0% | $3.82M-22.7% | $1.81M-76.7% | $5.42M-4.5% | ||
| -$233.41M-289% | $115.13M+121% | $121.17M+113% | $77.74M+197% | $123.32M+127% | ||
| $601.58M+79,160% | $2.41M-50.9% | -$3.67M-100% | $2.52M-97.7% | $759K-99.9% | ||
| $86.88M+312% | -$107.12M+83.8% | -$25.52M-105% | -$40.11M+56.8% | -$41.03M-119% | ||
| -$282.73M-64.7% | -$227.49M-97.1% | -$147.13M-124% | -$122.98M+4.8% | -$171.7M-4.2% |
FAQ
- How much cash does Vaxcyte, Inc. generate?
- Vaxcyte, Inc. (PCVX) generated -$769.9M in operating cash flow over the trailing twelve months.
- What is Vaxcyte, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Vaxcyte, Inc.'s free cash flow was -$780.3M over the trailing twelve months, down 61.9% year over year.
- Where does Vaxcyte, Inc.'s cash flow data come from?
- Every line is extracted from Vaxcyte, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.